Thursday · October 29, 2026

 ·  Daily  ·  Newsletters

Resonance network: Quantum InsiderSpace Insider

Technology & Infrastructure · Applications & agents

PharmaScroll Launches AI Chatbot to Advance Data Analytics in Pharma

PharmaScroll has unveiled Self-Serve AI, a generative AI chatbot designed to streamline research and analytics for the pharmaceutical and healthcare industries. Unlike traditional tools, Self-Serve AI draws insights from diverse data sources, including payer data, APLD, sales metrics, claims analysis, and, notably, unconventional sources like patient forums and blogs. This approach aims to provide a more comprehensive understanding of market trends and patient perspectives.

PharmaScroll director Sahil Singla described the chatbot as “a comprehensive, adaptable, and secure tool” that leverages both qualitative and quantitative data to enable smarter decision-making in a rapidly evolving industry. Its innovative integration of non-traditional data sources sets it apart, offering organizations a broader view of healthcare conversations and trends.

Earlier this year, PharmaScroll introduced SocialBI, a tool that collects healthcare-related discussions from social media platforms like X (formerly Twitter), Reddit, and forums such as WebMD. Singla highlighted its transformative potential for understanding patient behavior, identifying trends, and enhancing strategic planning.

While these tools highlight the promise of AI in expanding data analytics, challenges remain. Social media data, often prone to bias and misinformation, requires careful processing to ensure actionable insights. Despite this, PharmaScroll’s innovations demonstrate the growing role of AI in reshaping pharmaceutical and healthcare decision-making.

James Dargan
About the author
James Dargan

James Dargan is a writer and researcher at The AI Insider. His focus is on the AI startup ecosystem and he writes articles on the space that have a tone accessible to the average reader.

The AI economy, every weekday morning

The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.